TKI Discontinuation in CML Patients of China

Clinical trial NCT03251352 · UNKNOWN

Trial details

NCT number: NCT03251352
Sponsor: Shenzhen Second People's Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Leukemia Myelogenous Chronic BCR-ABL (Breakpoint Cluster Region-abelson Murine Leukemia)Positive

Start date: 2017-03-01
Primary completion: 2022-09-30
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.